Abstract |
The effects of a neuronal nitric oxide synthase (nNOS) inhibitor, 1-(2-trifluoromethylphenyl)imidazole (TRIM) on rat sensory saphenous nerve-induced neurogenic inflammation were investigated. TRIM (50 mg kg-1, i.p.), but not 2-trifluoromethylphenol ( TRIMPOH) which lacks nNOS inhibitory activity, inhibited neurogenic oedema by 55.8 +/- 6.5% (n = 6, p < 0.05). The effect of TRIM was partially reversed by L-arginine (100 mg kg-1, i.v., p < 0.01). TRIM also caused a reduction (p < 0.05) in neurogenic vasodilatation but had no effect on neuropeptide responses induced by substance P + CGRP. Topically applied TRIM (100 microliters of 150-250 mg ml-1) inhibited neurogenic oedema (p < 0.01). Thus, use of this recently described nNOS inhibitor has provided new evidence to further the hypothesis that nNOS plays a role in modulating sensory nerve-mediated neurogenic inflammation.
|
Authors | P K Towler, G S Bennett, P K Moore, S D Brain |
Journal | Neuroreport
(Neuroreport)
Vol. 9
Issue 7
Pg. 1513-8
(May 11 1998)
ISSN: 0959-4965 [Print] England |
PMID | 9631458
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- 2-trifluoromethylphenol
- Enzyme Inhibitors
- Hydrocarbons, Fluorinated
- Imidazoles
- Phenols
- Vasoconstrictor Agents
- 1-(2-trifluoromethylphenyl)imidazole
- Arginine
- Nitric Oxide Synthase
- Nitric Oxide Synthase Type I
- Nos1 protein, rat
|
Topics |
- Animals
- Arginine
(pharmacology)
- Edema
(drug therapy, physiopathology)
- Electric Stimulation
- Enzyme Inhibitors
(pharmacology)
- Hindlimb
- Hydrocarbons, Fluorinated
(pharmacology)
- Imidazoles
(pharmacology)
- Inflammation
(drug therapy, physiopathology)
- Male
- Nitric Oxide Synthase
(antagonists & inhibitors)
- Nitric Oxide Synthase Type I
- Peripheral Nerves
(drug effects, physiology, physiopathology)
- Phenols
(pharmacology)
- Rats
- Rats, Wistar
- Vasoconstrictor Agents
(pharmacology)
- Vasodilation
(drug effects)
|